PAVmed (PAVM) Accumulated Expenses (2015 - 2025)

PAVmed has reported Accumulated Expenses for 11 years, with the latest figure at $2.5 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses fell 51.97% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2025 stood at $2.5 million (down 51.97% YoY), and the FY2025 full-year result was $2.5 million, down 51.97% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $2.5 million, down from $2.7 million in the prior quarter.
• The five-year high for Accumulated Expenses was $6.8 million in Q2 2024, with the low at $1.1 million in Q1 2021.
• Average Accumulated Expenses over 5 years is $3.6 million, with a median of $3.2 million recorded in 2022.
• Year-over-year, Accumulated Expenses soared 208.74% in 2022 and plunged 65.69% in 2025.
• Tracing PAVM's Accumulated Expenses over 5 years: stood at $4.3 million in 2021, then decreased by 13.01% to $3.7 million in 2022, then surged by 78.84% to $6.6 million in 2023, then declined by 21.88% to $5.2 million in 2024, then plunged by 51.97% to $2.5 million in 2025.
• The last three Accumulated Expenses figures came in at $2.5 million (Q4 2025), $2.7 million (Q3 2025), and $2.8 million (Q2 2025), per Business Quant data.

Peer Comparison